Menu Search
Equities

EKF Diagnostics Holdings PLC

EKF:LSE

EKF Diagnostics Holdings PLC

Actions
Health CareMedical Equipment and Services
  • Price (GBX)27.65
  • Today's Change0.150 / 0.55%
  • Shares traded141.74k
  • 1 Year change-1.25%
  • Beta0.3635
Data delayed at least 20 minutes, as of Nov 08 2024 16:03 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year EKF Diagnostics Holdings PLC had revenues fall -21.05% from 66.64m to 52.61m, though the company grew net income from a loss of 10.10m to a gain of 2.35m.
Gross margin48.05%
Net profit margin10.05%
Operating margin10.24%
Return on assets6.34%
Return on equity7.18%
Return on investment7.35%
More ▼

Cash flow in GBPView more

In 2023, cash reserves at EKF Diagnostics Holdings PLC fell by 3.85m. However, the company earned 6.31m from its operations for a Cash Flow Margin of 12.00%. In addition the company used 5.64m on investing activities and also paid 3.65m in financing cash flows.
Cash flow per share0.022
Price/Cash flow per share12.55
Book value per share0.1516
Tangible book value per share0.0867
More ▼

Balance sheet in GBPView more

EKF Diagnostics Holdings PLC uses little debt in its capital structure as supported by a debt to capital ratio of 1.75%.
Current ratio4.60
Quick ratio3.08
Total debt/total equity0.0181
Total debt/total capital0.0175
More ▼

Growth rates in GBP

Year on year, growth in earnings per share excluding extraordinary items increased 123.45%. Additionally, five year annualized earnings per share growth ranks below the industry average relative to its peers.
EPS growth(5 years)-25.06
EPS (TTM) vs
TTM 1 year ago		137.76
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.